Lenvatinib Plus Pembrolizumab in Patients With Advanced Endometrial Cancer

PURPOSE: Patients with advanced endometrial carcinoma have limited treatment options. We report final primary efficacy analysis results for a patient cohort with advanced endometrial carcinoma receiving lenvatinib plus pembrolizumab in an ongoing phase Ib/II study of selected solid tumors. METHODS:...

Descripción completa

Detalles Bibliográficos
Autores principales: Makker, Vicky, Taylor, Matthew H., Aghajanian, Carol, Oaknin, Ana, Mier, James, Cohn, Allen L., Romeo, Margarita, Bratos, Raquel, Brose, Marcia S., DiSimone, Christopher, Messing, Mark, Stepan, Daniel E., Dutcus, Corina E., Wu, Jane, Schmidt, Emmett V., Orlowski, Robert, Sachdev, Pallavi, Shumaker, Robert, Casado Herraez, Antonio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Clinical Oncology 2020
Materias:
ORIGINAL REPORTS
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7479759/
https://www.ncbi.nlm.nih.gov/pubmed/32167863
http://dx.doi.org/10.1200/JCO.19.02627

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7479759/
https://www.ncbi.nlm.nih.gov/pubmed/32167863
http://dx.doi.org/10.1200/JCO.19.02627

Ejemplares similares